NEW YORK (AVAFIN) -- Myriad Genetics options contracts experienced a new 3-month record for both call and put contracts where a
total of 5,427 call and 5,081 put contracts were traded in the busy trading session. The contract
spread yielded a 0.94 put/call ratio.
Options can be used as predictors of stock behavior. Investors can use put/call ratios as
technical indicators to read for signs of institutional sentiment. The put/call ratios
offer insight to investors and can be used as either a direct or contrarian indicator
for trading decisions. Unusual volume provides reliable clues that the stock is expected
to make a move.
Shares of Myriad Genetics settled at $23.34, up $0.56 (+2.46%) in the last trading session.
The shares of the stock had an intraday low of $22.76 and high of $23.94. To date, the stock has gained 14.81% within the last quarter.
The stock's 52 week low is $17.51 and 52 week high is $25.89.